WASHINGTON, Sept 26 (Reuters) - U.S. authorities are considering requiring Johnson & Johnson (JNJ.N: Quote, Profile, Research) to license a key cardiac stent technology to Abbott Laboratories Inc. (

http://c.moreover.com/click/here.pl?r397103187